APA (7th ed.) Citation

Takahiro Kato, Yoko Yasuda, Hitomi Okamoto, Yuji Saito, Yusuke Nakano, Katsuhiko Matsuura, . . . Tetsuya Amano. (2023). Total body fluid is the factor that affects the pharmacokinetics of tolvaptan, and its efficacy, in acute worsening heart failure patients. Wiley.

Chicago Style (17th ed.) Citation

Takahiro Kato, Yoko Yasuda, Hitomi Okamoto, Yuji Saito, Yusuke Nakano, Katsuhiko Matsuura, Masafumi Oonishi, and Tetsuya Amano. Total Body Fluid Is the Factor That Affects the Pharmacokinetics of Tolvaptan, and Its Efficacy, in Acute Worsening Heart Failure Patients. Wiley, 2023.

MLA (9th ed.) Citation

Takahiro Kato, et al. Total Body Fluid Is the Factor That Affects the Pharmacokinetics of Tolvaptan, and Its Efficacy, in Acute Worsening Heart Failure Patients. Wiley, 2023.